CASE REPORT
Published on 08 Aug 2025
Durable response to venetoclax, azacytidine, and ruxolitinib in chronic-phase myelofibrosis resistant to ruxolitinib: a case report and literature review
doi 10.3389/fonc.2025.1644661
- 395 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- BCL-2 Family Inhibitors in Hematologic Malignancies
BCL-2 Family Inhibitors in Hematologic Malignancies
4,147
Total downloads
18k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Accepted on 24 Jul 2025
Simnotrelvir/Ritonavir are effective in shortening the course of prolonged SARS-CoV-2 infection during anti-CD20 maintenance therapy in patients with follicular lymphoma
doi 10.3389/fonc.2025.1583932
- 168 views
CASE REPORT
Published on 01 Jul 2025
Effective venetoclax treatment for indolent T-cell lymphoma of the gastrointestinal tract: a case report and literature review
doi 10.3389/fimmu.2025.1593343
- 1,052 views
REVIEW
Published on 22 Apr 2025
Targeting BCL2 in Waldenström macroglobulinemia: from biology to treatment management
doi 10.3389/fonc.2025.1564869
- 1,646 views
MINI REVIEW
Published on 21 Mar 2025
The potential role of BCL-2 inhibition in amyloidosis and plasma cell leukemia
doi 10.3389/fonc.2025.1549891
- 2,483 views
REVIEW
Published on 21 Jan 2025
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
doi 10.3389/fonc.2024.1501950
- 2,246 views
- 1 citation
ORIGINAL RESEARCH
Published on 09 Dec 2024
Efficacy and safety of hypomethylating agents in the treatment of AML/MDS patients relapsed post allogenetic hematopoietic stem cell transplantation
doi 10.3389/fonc.2024.1465334
- 1,088 views
- 1 citation
MINI REVIEW
Published on 04 Nov 2024
Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma
doi 10.3389/fonc.2024.1490202
- 2,777 views
- 2 citations
BRIEF RESEARCH REPORT
Published on 08 Apr 2024
Co-operation of MCL-1 and BCL-XL anti-apoptotic proteins in stromal protection of MM cells from carfilzomib mediated cytotoxicity
doi 10.3389/fonc.2024.1394393
- 1,749 views
- 1 citation
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.